HLS Therapeutics Brief: Q4 2023 Revenue Was US$15.9 Million, Adjusted EBITDA Was $5.3 Million and Cash From Operations Was $3.7 Million
HLS Therapeutics Brief: Q4 2023 Revenue Was US$15.9 Million, Adjusted EBITDA Was $5.3 Million and Cash From Operations Was $3.7 Million
HLS Therapeutics简介：2023年第四季度收入为1,590万美元，调整后的息税折旧摊销前利润为530万美元，运营现金为370万美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册